Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In this study we would like to clarify the effect of long lasting Crohn's Disease on motility of the gastrointestinal system in patient and the effect regarding sleep disturbances. This will be done with a newly developed 3D-Motility-and-Transit-detector (Motilis Medica, Schweiz) and the well known polysomnographic equipment.
Our hypothesises are:
Patients with ileocoecal and/or colonic CD in remission and gastrointestinal symptoms have abnormal colonic transit (primary endpoint).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Gl motility and sleep pattern |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Total and segmental gastrointestinal transit time in patients suffering from CD | Expected average total transit time less than two days, analyzed after 2-3 days | |
| Abnormal sleep pattern in patients with ileocoecal and/or colonic CD in remission | Recorded during a single night, analyzed one of the two following days. |
| Measure | Description | Time Frame |
|---|---|---|
| Gastric emptying in CD patients | Less than 1 day, analyzed after 1-3 days | |
| Small intestinal transit time in CD patients | Less than 2 days, analyzed after 2-3 days | |
Not provided
Inclusion Criteria:
Patients with CD based on accepted endoscopic and histological criteria (according to ECCO guidelines (17) )
Age ≥18 years
A minimum disease duration of five years
Remission defined by Faecal calprotectin < 100 and CRP level within normal values for a minimum of 1 month
Baseline values:
Ileocoecal and/or colic localization of disease (Montreal phenotype classification)
One or more IBS-like-symptoms (abdominal pain and discomfort, diarrhea, constipation)
Exclusion Criteria:
Not provided
Not provided
Patients with quiescent Crohn's disease who still have gastrointestinal complaints.Found in the out-patient clinic at Department V (Gastroenterology and Hepatology).
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Katrine O. Andersen | Contact | 004542301641 | koaaarhus@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Klaus Krogh, MD, Dr. Med | Department of Gastroenterology and Hepatology, Aarhus University Hospital | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Aarhus University Hospital, Department of Gastroenterology and Hepatology | Aarhus C | 8000 | Denmark |
Not provided
| ID | Term |
|---|---|
| D003424 | Crohn Disease |
| D015212 | Inflammatory Bowel Diseases |
| D020447 | Parasomnias |
| ID | Term |
|---|---|
| D005759 | Gastroenteritis |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
| D007410 | Intestinal Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
A single blood sample (TNF-α, IL-1, IL-6) will be taken at the laboratory.
| Segmental colonic transit time in CD patients |
| Average less than 2 day, analyzed after 2-3 days |
| Nocturnal basic colonic activity in patients with ileocoecal and/or colonic CD in remission and sleep disturbances | Recorded during one night, analyzed one of the two following days |
| D012893 | Sleep Wake Disorders |
| D009422 | Nervous System Diseases |
| D001523 | Mental Disorders |